+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 12 Actively Recruiting clinical trials

E

Actively Recruiting

Researchers are evaluating a new digital tool called Prioritize Personalize Prescribe Exercise P3-EX designed to help clinicians prescribe customized exercise plans to patients with cardiovascular disease CVD risk factors such as obesity, hypertension, dyslipidemia, and diabetes. This pilot randomized controlled crossover trial aims to test the usability and satisfaction of P3-EX compared to a standard exercise prescription method called the American College of Sports Medicine Physical Activity Vital Sign ACSM-PAVS. Clinicians including physicians, physician assistants, and advanced practice registered nurses will recruit patients with CVD risk factors and deliver exercise prescriptions using either P3-EX or ACSM-PAVS in a random sequence crossover design. Patients will follow their assigned exercise program for 12 weeks with virtual weekly oversight from University of Connecticut Graduate Research Assistants. Each patient will receive an exercise information packet, virtual guidance visits, and weekly progressive exercise goals by email. Clinicians and patients will complete usability and satisfaction questionnaires within 48 hours after each exercise prescription delivery. Participants will attend in-person visits at the start and end of the study to assess cardiovascular health, physical activity levels using accelerometers, and exercise adherence recorded in self-report diaries. Blood tests for lipid and glucose profiles will be performed at local labs. The study measures feasibility and acceptability of P3-EX as the primary outcome, and explores changes in patient cardiovascular risk factors, physical activity, and exercise adherence as secondary outcomes. The total participation involves baseline assessments, 12 weeks of exercise intervention, and post-intervention evaluations.

Age: 18Years - 64YearsAll GendersPhase Not Applicable
3 locations
S

Actively Recruiting

Researchers are studying individuals who have undergone anterior cruciate ligament reconstruction ACLR surgery to evaluate how specific asymmetric walking patterns can help restore balanced limb loading. The study aims to compare two different walking speed differences applied between the legs to see which better improves gait symmetry and reduces harmful knee stress. Computational modeling and machine learning will also be used to model knee loading in clinical settings to identify the best asymmetric walking approach for these patients. Participants will take part in two separate asymmetric walking sessions on different days, with at least three weeks between sessions. One session involves walking where one leg moves at 1.0 ms and the other at 1.25 ms a 0.25 ms speed difference, and the other session involves a 0.50 ms difference where one leg moves at 1.0 ms and the other at 1.5 ms. Each session includes three 15-minute asymmetric walking intervals followed by 5-minute periods of walking symmetrically at 1.0 ms. The order of sessions is randomized for each participant. During the study, researchers will gather data on walking patterns and knee joint loading before and immediately after the sessions. They will measure changes in loading rate, ground reaction forces, stride time, and knee loading using patient-specific simulations. The study will assess how these asymmetric walking protocols influence gait and joint stress in post-ACLR individuals. The total participation spans across the two walking sessions with a minimum three-week gap between them.

Age: 18Years - 30YearsAll GendersPhase Not Applicable
1 location
E

Actively Recruiting

Healthy Volunteer

Researchers are evaluating the effects of blackcurrant BC supplementation on bone density and gut microbiome composition in postmenopausal females aged 45 to 70 years. This trial focuses on postmenopausal osteoporosis, a bone disorder caused by estrogen deficiency leading to bone loss. The study aims to understand how BC and gut microbiota interact to reduce bone loss using a multi-omics approach that examines immune, endocrine, genetic, and metabolic factors. Participants will be randomly assigned to one of three groups low-dose BC extract, high-dose BC extract, or placebo. Those in BC groups will consume three capsules daily containing varying amounts of BC extract, while the placebo group will consume capsules without BC. The intervention lasts 12 months, during which researchers will monitor bone density, biomarkers of bone remodeling, gut microbiome changes, and various protein, metabolite, and genetic markers. During the study, participants will undergo three blood draws, three stool collections, and three bone scans to assess changes over time. Researchers will measure bone mineral density at several sites and analyze biomarkers related to bone health, immune and endocrine functions, and gut bacteria. The study includes careful monitoring of diet and exercise to support reliable results. Total participation spans one year with regular assessments to evaluate BCs potential impact on bone health and gut microbiota.

Age: 45Years - 70YearsFEMALEPhase 1
1 location
S

Actively Recruiting

Healthy Volunteer

Researchers are studying the effects of Cannabidiol CBD on fear learning and anxiety in college students who have high levels of social anxiety. This early phase 1 trial recruits undergraduates at the University of Connecticut who show elevated social anxiety on standard tests. The study aims to see if CBD can help reduce fear responses during a controlled fear conditioning experiment. Participants will undergo a fear conditioning test where they learn to associate one face with a mild wrist shock and another face with no shock. After learning, half of the participants will receive a single 600 mg dose of CBD isolate gel capsules, while the other half will receive placebo capsules. Following this, participants will be exposed to the faces again without shocks to measure how quickly and effectively their fear responses diminish. Throughout the study, researchers will monitor participants electrodermal responses and subjective fear ratings using a visual scale to assess fear extinction. The primary outcome is the electrodermal activity measured over 20 minutes. The trial is randomized and double-blind, with all participants completing the study within a single session. Safety and response data will be collected during this time to evaluate how CBD affects anxiety and learning.

Age: 18Years - 50YearsAll GendersEarly Phase 1
1 location
S

Actively Recruiting

Researchers are evaluating whether a tailored amino acid supplement can help adults with Parkinsons disease improve their nutrition, metabolic function, body composition, and physical and mental health. The study compares this specially designed supplement to a placebo to understand its impact on essential amino acid levels, antioxidant status, and oxidative stress in people living with Parkinsons. Participants will take either the targeted amino acid supplement or a placebo daily for six months. The supplement includes a blend of essential, conditionally essential, and non-essential amino acids tailored for Parkinsons disease nutritional needs. The placebo consists of an inert amino acid used as a control. The study includes baseline, 3-month, and 6-month assessments. During the study, participants will visit the lab three times for fasting blood draws, body composition measurements using bioelectrical impedance and ultrasound, and physical and mental health testing. They will also keep diaries of their food and supplement intake. Researchers will measure amino acid bioavailability, oxidative stress, body composition, physical function, and self-reported outcomes such as quality of life, fatigue, sleep, mood, anxiety, motivation, and depression over the course of the trial.

Age: 50Years - 90YearsAll GendersPhase Not Applicable
2 locations
M

Actively Recruiting

This research aims to evaluate the Diabetes LIVE JustICE application, designed to support diabetes self-management among formerly incarcerated individuals transitioning to supervised community housing. This group experiences a higher rate of diabetes and faces challenges such as limited diabetes knowledge, cognitive impairment, and restricted access to healthcare skills. The study uses a randomized clinical trial design with repeated assessments at 0, 6, and 12 weeks to examine feasibility, acceptability, and preliminary effects on behavior and clinical outcomes including glycemic control. Participants will be assigned to either the Diabetes LIVE JustICE intervention or a control group receiving enhanced pre-release diabetes education. The intervention group accesses a multi-user virtual environment via IOSAndroid mobile devices, offering real-time communication, instructor-led education, support sessions, and interactive resources over six weekly 1-hour sessions plus a support hour. The control group receives nurse-delivered diabetes education and literacy-tailored materials. The six-week series will be run multiple times over 18 months. During the study, participants will be monitored for recruitment, engagement, participation rates, and user experience. Assessments include diabetes knowledge, emotional distress, self-care behaviors, social support, perceived competence, and metabolic indicators like A1C. Focus groups will gather feedback on acceptability. Researchers will track changes from baseline through week 12, aiming to understand the interventions impact on diabetes management and support for this vulnerable population.

Age: 18Years +All GendersPhase Not Applicable
2 locations
S

Actively Recruiting

Healthy Volunteer

This research aims to study the effects of consuming freeze-dried grape powder on immune system markers in healthy middle-aged and older adults between 50 and 75 years old. The study focuses on how grapes might influence immune function, inflammation, and metabolism changes related to aging. Grapes contain nutrients and antioxidants like resveratrol, quercetin, vitamin K, and fiber, which are known to support heart and immune health, but their impact on immune profiles with aging is not well understood. Participants will consume a freeze-dried grape powder and a control powder without grape compounds as a beverage daily for 4 weeks each, in a randomized, double-blind crossover design. They will avoid eating grapes and certain other polyphenol-rich foods and beverages during the 13-week study. The study includes 7 visits over this period to monitor participants and collect data. During the study, participants will complete surveys about diet, physical activity, and medical history, provide blood samples, and have body weight measured. Researchers will assess immune markers, including lipopolysaccharide-induced interleukin-1 beta secretion from immune cells after 4 weeks. The total participation time is about 6.25 hours across the 13 weeks, with close monitoring to understand how grape consumption affects immune profiles in healthy aging adults.

Age: 50Years - 75YearsAll GendersPhase Not Applicable
1 location
T

Actively Recruiting

This research aims to find the best number of behavioral counseling sessions needed to help people with HIV improve and maintain their treatment adherence and viral suppression. It is the first dose-determination trial that studies how much counseling is needed for different patients facing various individual and social challenges. The results will help guide health policy and how behavioral interventions are used to support lasting HIV viral suppression among patients on antiretroviral therapy ART. Participants who are confirmed HIV positive and non-adherent to ART will be randomly assigned to one of two groups. One group receives up to 16 weekly phone counseling sessions that adjust based on their response to achieve viral suppression. The other group gets a fixed dose of five weekly counseling sessions over the phone focused on improving medication adherence. Counseling aims to support cognitive-behavioral skills for HIV treatment adherence, with follow-up assessments for 12 months. During the study, researchers will regularly measure changes in ART adherence and HIV viral load from baseline through 12 months. Participants who respond but later experience viral rebound can receive additional counseling sessions. The study will analyze how counseling dose relates to patient subgroups and costs to help make informed decisions about resource allocation for behavioral interventions. Overall, the trial involves phone counseling sessions, adherence and viral load monitoring, and 12 months of follow-up to assess outcomes and intervention dose effectiveness.

Age: 18Years +All GendersPhase Not Applicable
2 locations
S

Actively Recruiting

Healthy Volunteer

Researchers are investigating how daily consumption of egg whites versus whole eggs affects gut health, HDL cholesterol, metabolic and immune profiles in adults aged 18 to 50 with normal or obese body mass indexes BMI. The study aims to determine if these effects vary based on initial gut microbiome profiles, sex, and BMI status. The trial focuses on basic science to better understand these relationships. Participants will consume either 3 large egg whites or 3 large whole eggs daily for 4 weeks each, following a randomized crossover design. There will be periods without egg consumption totaling 8 weeks during the study. The study compares egg whites and whole eggs as interventions to evaluate their effects on various health markers. During the study, participants will complete dietary and physical activity surveys and provide blood and stool samples to assess gut microbiome, metabolic, and immune changes. The primary outcome is the change in serum concentration of large HDL particles measured after each 4-week diet period. The total study duration includes these diet periods and egg avoidance phases, with ongoing monitoring throughout.

Age: 18Years - 50YearsAll GendersPhase Not Applicable
1 location
I

Actively Recruiting

Healthy Volunteer

Researchers are evaluating a clinic-level multidimensional intervention designed to improve clinical decision making, reduce regulatory confusion, alleviate legal and financial concerns, and increase take-home dosing THD of methadone in opioid treatment programs OTPs. This study focuses on adults with opioid use disorder OUD and aims to address disparities in methadone treatment access and retention, especially among BlackAfrican American and Latinx populations. The intervention is tested through a stepped-wedge randomized controlled trial involving 36 OTPs to compare the new approach with usual treatment practices. The intervention includes specific dashboards derived from state databases to support OTP staff in applying regulatory flexibility for methadone THD. Over five years, the trial enrolls OTPs in six cohorts, each receiving a six-month clinic-level intervention at staggered times. The study spans data collection and intervention phases, aiming to increase THD uptake by addressing staff knowledge gaps, training needs, and organizational beliefs. The project is a collaborative effort involving several academic institutions and state addiction services. Participants include clinic staff from selected OTPs and patients aged 18 or older who have received take-home methadone for at least 30 days. The study measures changes in 7-, 14-, and 28-day THD prescriptions, retention in care, emergency department visits, hospitalizations, and all-cause mortality before and after the intervention. Data is collected through state administrative databases and qualitative interviews, with the trial continuing through August 2027 to evaluate the interventions effects on care retention and safety outcomes.

Age: 18Years +All GendersPhase Not Applicable
4 locations

1-10 of 12

1